What is One BIO?
One.bio is a biotechnology firm dedicated to improving healthspan by reintroducing active plant fibers into everyday food products. Leveraging cutting-edge technology, the company specializes in isolating short-chain fibers from plants, making them easily consumable and highly effective for invigorating the microbiome and bolstering the immune system. One.bio's innovative solutions are designed to address malnutrition in modern diets and aim to eradicate inflammatory diseases, enabling individuals to thrive. The company's focus on scientific advancement positions it at the forefront of the health and nutrition industry.
How much funding has One BIO raised?
One BIO has raised a total of $27M across 1 funding round:
Series A
$27M
Series A (2024): $27M with participation from Better, Skyviews Life Science, Bayer, Alpha Edison, ACRE, Morado, and iSelect
Key Investors in One BIO
Better
Better Home & Finance Holding Company, though primarily a homeownership company, participated in this funding round, indicating a potential diversification or strategic interest beyond its core operations.
Skyviews Life Science
Skyviews Life Science, an advisory firm specializing in precision health and longevity, brings expertise in biotechnology and advanced nutrition, aligning perfectly with One.bio's mission.
Bayer
Bayer, a global life science enterprise with divisions in healthcare and nutrition, provides significant strategic backing and industry insight, reinforcing One.bio's potential in the health and nutrition sectors.
What's next for One BIO?
With the recent major strategic investment, One.bio is poised for accelerated growth and expanded market reach. This capital will likely fuel further research and development into novel fiber-extraction techniques and the integration of their technology into a wider array of food products. Strategic partnerships, potentially with entities like Bayer, will be crucial for scaling production and distribution. The company's focus on combating inflammatory diseases and enhancing overall well-being suggests a future trajectory aimed at becoming a leader in preventative health and functional foods, potentially exploring further funding rounds to support global expansion and clinical validation.
See full One BIO company page
